Granulocyte-Macrophage Colony-Stimulating Factor Regulates the Functional Adhesive State of Very Late Antigen-4 Expressed by Eosinophils

Journal of Immunology

Volumn 158, Issue 2, 1997, Pages 919-927

  Sung, K L Paul ^a,d   Yang, Li ^a   Elices, Mariano ^b   Jin, Gang ^a   Sriramarao, P ^c   Broide, David H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CYTEL CORPORATION   (United States)

^c La Jolla Institute for Experimental Medicine   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; GLUTAMYL ISOLEUCYL LEUCYL ASPARTYL VALINE; GLUTAMYL-ISOLEUCYL-LEUCYL-ASPARTYL-VALINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HOMING RECEPTOR; INTEGRIN; OLIGOPEPTIDE; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN; VERY LATE ACTIVATION ANTIGEN 4;

ARTICLE; BIOSYNTHESIS; CELL ADHESION; DRUG EFFECT; EOSINOPHIL; HUMAN; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; VASCULAR ENDOTHELIUM;

CARRIER PROTEINS; CELL ADHESION; ENDOTHELIUM, VASCULAR; EOSINOPHILS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTEGRIN ALPHA4BETA1; INTEGRINS; OLIGOPEPTIDES; PROTEIN BINDING; RECEPTORS, LYMPHOCYTE HOMING; RECEPTORS, VERY LATE ANTIGEN; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0031567976     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Weller, P. F. 1991. The immunobiology of eosinophils. N. Engl. J. Med. 324: 1110.
2. Broide, D. H., M. Paine, and G. Firestein. 1992. Eosinophils express IL-5 and GM-CSF mRNA at sites of allergic inflammation in asthmatics. J. Clin. Invest. 90:1414.
3. Gleich, G. J., C. R. Adolphson, and K. M. Leiferman. 1993. The biology of the eosinophilic leukocyte. Annu. Rev. Med. 44:85.
4. Broide, D H., G. J. Gleich, A. Cuomo, D. Coburn, E. Federman, L. Schwartz, and S. I. Wasserman. 1991. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J. Allergy Clin. Immunol. 88:637.
5. Sriramarao P., U. H. Von Andrian, E. C. Butcher, M. A. Bourdon, and D. H. Broide. 1994. L-selectin and VLA-4 integrin promote eosinophil rolling at physiological shear rates in vivo. J. Immunol. 153:4238.
6. Butcher, E. C. 1991. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67:1033.
7. 2 integrin-mediated neutrophil adhesion at physiological shear rates in vivo. Am. J. Physiol. 263:H1034.
8. Lawrence, M. B., and T. A. Springer. 1991. Leukocytes roll on a selectin at physiological flow rates: distinction from and prerequisite for adhesion through integrins. Cell 65:859.
9. Berlin, C., R. F. Bargatze, J. J. Campbell, U. H. Von Andrian, M. C. Szabo, S. R. Hasslen, R. D. Nelson, E. L. Berg, S. L. Erlandsen, and E. C. Butcher. 1995. Alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80:413.
10. Alon, R., P. D. Kassner, M. W. Carr, E. B. Finger, M. E. Hemler, and T. A. Springer. 1995. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J. Cell Biol. 128:1243.
11. Hynes, R. O. 1992. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11.
12. 4 integrins in vivo. J. Clin. Invest. 94:1722.
13. Masumoto, A., and M. E. Hemler. 1993. Multiple activation states of VLA-4. Mechanistic differences between adhesion to CS1/fibronectin and to vascular cell adhesion molecule-1. J. Biol. Chem. 268:228.
14. Osborn, L., C. Vassallo, and C. D. Benjamin. 1992. Activated endothelium binds lymphocytes through a novel binding site in the alternatively spliced domain of vascular cell adhesion molecule-1. J. Exp. Med. 176:99.
15. 4 integrin counter-receptor on stimulated endothelium. J. Exp. Med. 175:1433.
16. Elices, M. J., L. Osborn, Y. Takada, C. Crouse, S. Lubowsky, M. E. Hemler, and R. R. Lobb. 1990. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60:577.
17. Vonderheide, R. H., T. F. Tedder, T. A. Springer, and D. E. Staunton. 1994. Residues within a conserved amino acid motif of domains 1 and 4 of VCAM-1 are required for binding to VLA-4. J. Cell Biol. 125:215.
18. 1). J. Cell Biol. 124:601.
19. Komoriya, A., L. J. Green, M. Mervic, S. S. Yamada, K. M. Yamada, and M. J. Humphries. 1991. The minimal essential sequence for a major cell type specific adhesion site (CS1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine. J. Biol. Chem. 266:15075.
20. 1. J. Biol. Chem. 269:4005.
21. 4 epitopes. J. Biol. Chem. 266:10241.
22. Bagby, G. C., G. Shaw, M. C. Heinrich, S. Hefeneider, M. A. Brown, T. G. De Loughery, G. M. Segal, and L. Band. 1990. Interleukin-1 stimulation stabilizes GM-CSF mRNA in human vascular endothelial cells: preliminary studies on the role of the 3′ AU rich motif. Prog. Clin. Biol. Res. 352:233.
23. Sung, K.-L. P., L. A. Sung, M. Crimmins, S. J. Burakoff, and S. Chien. 1986. Determination of junction avidity of cytolytic T cell and target cell. Science 234:1405.
24. Sung, K.-L. P., M. M. Frojmovic, T. E. O'Toole, C. Zhu, M. H. Ginsberg, and S. Chien. 1993. Determination of adhesion force between single cell pairs generated by activated GpIIb-IIIa receptors. Blood 81:419.
25. Sung, K.-L. P., M. K. Kwan, and W. H. Akeson. 1994. Adhesion strength of human ligament fibroblasts. J. Biomech. Engin. 116:237.
26. 1 integrin (VLA-4) ligands in arthritis. I. Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes. J. Immunol. 149:1424.
27. Sung, K.-L. P., E. Saldivar, and L. Phillips. 1994. Interleukin-1β induces differential adhesiveness on human endothelial cell surfaces. Biochem. Biophys. Res. Commun. 202:866.
28. Wayner, E. A., A. Garcia-Pardo, M. J. Humphries, J. A. McDonald, and W. G. Carter. 1989. Identification of characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J. Cell Biol. 109:1321.
29. lademarco, M. F., J. L. Barks, and D. C. Dean. 1995. Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-alpha in cultured endothelial cells. J. Clin. Invest. 95:264.
30. Walsh, G. M., J. J. Mermod, A. Hartnell, A. B. Kay, and A. J. Wardlaw. 1991. Human eosinophil but not neutrophil adherence to IL-1-stimulated human umbilical vein endothelial cells is alpha 4 beta 1 (very late antigen-4) dependent. J. Immunol. 146:3419.
31. Broide, D. H., and G. S. Firestein. 1991. Endobronchial allergen challenge in asthma: identification of cellular source of GM-CSF by in situ hybridization. J. Clin. Invest. 88:1048.
32. 2 integrin (Mac-1) and L-selectin (LECAM-1) adherence receptors on human neutrophils by high-resolution field emission SEM. J. Histochem. Cytochem. 41:327.
33. Kieffer, N., and D. R. Phillips. 1990. Platelet membrane glycoproteins: functions in cellular interactions. Annu. Rev. Cell Biol. 6:329.
34. Phillips, D. R., I. F. Charo, and R. M. Scarborough. 1991. GPIIb-IIIa: the responsive integrin. Cell 65:359.
35. Arnaout, M. A. 1990. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 75:1037.
36. Larson, R. S., and T. A. Springer. 1990. Structure and function of leukocyte integrins. Immunol. Rev. 114:181.
37. 3 subunit is sensitive to stimulation. J. Biol. Chem. 266:14202.
38. 3, integrin (platelet GPIIb-IIIa) is an intrinsic property of the receptor. Cell Regul. 1:883.
39. IIb. Science 254:845.
40. Sims, P. J., M. H. Ginsberg, E. F. Plow, and S. J. Shattil. 1991. Effect of platelet activation on the conformation of the plasma membrane glycoprotein IIb-IIIa complex. J. Biol. Chem. 266:7345.
41. Parise, L. V., S. L. Helgerson, B. Steiner, L. Nannizzi, and D. R. Phillips. 1987. Synthetic peptides derived from fibrinogen and fibronectin change the conformation of purified platelet glycoprotein IIb-IIIa. J. Biol. Chem. 262:12597.
42. 3 integrins: comparison of GPIIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells. J. Cell Biol. 113:451.
43. 2 (LFA-1, CD11a/CD18) cytoplasmic domain/cytoskeleton interaction. J. Exp. Med. 181:315.
44. Lotz, M., C. Burdsal, H. Erickson, and D. McClay. 1989. Cell adhesion to fibronectin and tenascin: quantitative measurements of initial binding and subsequent strengthening response. J. Cell Biol. 109:1795.
45. Worthen, G. S., B. Schwab, E. L. Elson. and G. P. Downey. 1989. Mechanics of stimulated neutrophils: cell stiffening induces retention in capillaries. Science 245:183.
46. Tözeren, A., L. Mackie, M. Lawrence, P. Chan, M. Dustin, and T. Springer. 1992. Micromanipulation of adhesion of phorbol 12-myristate-13-acetate-stimulated T lymphocytes to planar membranes containing intercellular adhesion molecule-1. Biophys. J. 63:247.
47. Hibbs, M. L., H. Xu, S. A. Stacker, and T. A. Springer, 1991. Regulation of adhesion to ICAM-1 by the cytoplasmic domain of LFA-1 integrin β subunit. Science 251:1611.
48. Springer, T. A. 1991. The cytoplasmic domain of the integrin lymphocyte function-associated antigen 1β subunit: sites required for binding to intercellular adhesion molecule 1 and the phorbol ester-stimulated phosphorylation site. J. Exp. Med. 174:1227.
49. Chan, P. Y., and A. Aruffo. 1993. VLA-4 integrin mediates lymphocyte migration on the inducible endotheual cell ligand VCAM-1 and the extracellular matrix ligand fibronectin. J. Biol. Chem. 268:24655.
50. Miyajima, A., A. L.-F. Mui, T. Ogorochi, and K, Sakamaki. 1993. Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 82:1960.
51. Sato, N., and A. Miyajima. 1994. Multimeric cytokine receptors: common versus specific functions. Curr. Opin. Cell Biol. 6:174.
52. Sato, N., K. Sakamaki, N. Terada, K. Arai, and A. Miyajima. 1993. Signal transduction by the high-affinity GM-CSF receptor: two distinct cytoplasmic regions of the common beta subunit responsible for different signaling. EMBO J. 12: 4181.
53. Vuori, K., and E. Ruoslahti. 1994. Association of insulin receptor substrate-1 with integrins. Science 266:1576.
54. 3, integrin associates with a 190-kDa protein that is phosphorylated on tyrosine in response to platelet-derived growth factor. J. Biol. Chem. 268:17270.